Outcome of heart failure with preserved ejection fraction in a population-based study - PubMed (original) (raw)
. 2006 Jul 20;355(3):260-9.
doi: 10.1056/NEJMoa051530.
Affiliations
- PMID: 16855266
- DOI: 10.1056/NEJMoa051530
Free article
Outcome of heart failure with preserved ejection fraction in a population-based study
R Sacha Bhatia et al. N Engl J Med. 2006.
Free article
Abstract
Background: The importance of heart failure with preserved ejection fraction is increasingly recognized. We conducted a study to evaluate the epidemiologic features and outcomes of patients with heart failure with preserved ejection fraction and to compare the findings with those from patients who had heart failure with reduced ejection fraction.
Methods: From April 1, 1999, through March 31, 2001, we studied 2802 patients admitted to 103 hospitals in the province of Ontario, Canada, with a discharge diagnosis of heart failure whose ejection fraction had also been assessed. The patients were categorized in three groups: those with an ejection fraction of less than 40 percent (heart failure with reduced ejection fraction), those with an ejection fraction of 40 to 50 percent (heart failure with borderline ejection fraction), and those with an ejection fraction of more than 50 percent (heart failure with preserved ejection fraction). Two groups were studied in detail: those with an ejection fraction of less than 40 percent and those with an ejection fraction of more than 50 percent. The main outcome measures were death within one year and readmission to the hospital for heart failure.
Results: Thirty-one percent of the patients had an ejection fraction of more than 50 percent. Patients with heart failure with preserved ejection fraction were more likely to be older and female and to have a history of hypertension and atrial fibrillation. The presenting history and clinical examination findings were similar for the two groups. The unadjusted mortality rates for patients with an ejection fraction of more than 50 percent were not significantly different from those for patients with an ejection fraction of less than 40 percent at 30 days (5 percent vs. 7 percent, P=0.08) and at 1 year (22 percent vs. 26 percent, P=0.07); the adjusted one-year mortality rates were also not significantly different in the two groups (hazard ratio, 1.13; 95 percent confidence interval, 0.94 to 1.36; P=0.18). The rates of readmission for heart failure and of in-hospital complications did not differ between the two groups.
Conclusions: Among patients presenting with new-onset heart failure, a substantial proportion had an ejection fraction of more than 50 percent. The survival of patients with heart failure with preserved ejection fraction was similar to that of patients with reduced ejection fraction.
Copyright 2006 Massachusetts Medical Society.
Comment in
- Diastolic heart failure--a common and lethal condition by any name.
Aurigemma GP. Aurigemma GP. N Engl J Med. 2006 Jul 20;355(3):308-10. doi: 10.1056/NEJMe068128. N Engl J Med. 2006. PMID: 16855273 No abstract available. - Heart failure with preserved ejection fraction.
Fiack CA, Farber HW. Fiack CA, et al. N Engl J Med. 2006 Oct 26;355(17):1828; author reply 1830-1. doi: 10.1056/NEJMc062229. N Engl J Med. 2006. PMID: 17065647 No abstract available. - Heart failure with preserved ejection fraction.
Ahmed A, Fleg JL, Gheorghiade M. Ahmed A, et al. N Engl J Med. 2006 Oct 26;355(17):1829-30; author reply 1830-1. N Engl J Med. 2006. PMID: 17072998 No abstract available. - Heart failure with preserved ejection fraction.
Kessler KM. Kessler KM. N Engl J Med. 2006 Oct 26;355(17):1829; author reply 1830-1. N Engl J Med. 2006. PMID: 17072999 No abstract available. - Heart failure with preserved ejection fraction.
Arias MA, Alonso-Fernández A, García-Río F. Arias MA, et al. N Engl J Med. 2006 Oct 26;355(17):1828-9; author reply 1830-1. N Engl J Med. 2006. PMID: 17073000 No abstract available. - 1 year mortality after first hospital admission for heart failure was similar in patients with preserved or reduced ejection fraction.
Ahmed A. Ahmed A. Evid Based Med. 2006 Dec;11(6):185. doi: 10.1136/ebm.11.6.185. Evid Based Med. 2006. PMID: 17213179 No abstract available.
Similar articles
- Trends in prevalence and outcome of heart failure with preserved ejection fraction.
Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Owan TE, et al. N Engl J Med. 2006 Jul 20;355(3):251-9. doi: 10.1056/NEJMoa052256. N Engl J Med. 2006. PMID: 16855265 - Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study.
Tribouilloy C, Rusinaru D, Mahjoub H, Soulière V, Lévy F, Peltier M, Slama M, Massy Z. Tribouilloy C, et al. Eur Heart J. 2008 Feb;29(3):339-47. doi: 10.1093/eurheartj/ehm554. Epub 2007 Dec 22. Eur Heart J. 2008. PMID: 18156618 - Prognostic factors and predictors of in-hospital mortality of patients with heart failure with preserved left ventricular ejection fraction.
Pérez de Isla L, Zamorano J, Hernández N, Contreras L, Rodrigo JL, Almería C, Aubele AL, Mataix L, Macaya C. Pérez de Isla L, et al. J Cardiovasc Med (Hagerstown). 2008 Oct;9(10):1011-5. doi: 10.2459/JCM.0b013e3282fbca87. J Cardiovasc Med (Hagerstown). 2008. PMID: 18799963 - Outcomes of heart failure with preserved ejection fraction in a Southeast Asian cohort.
Hoong CW, Lim CP, Gao F, Chen Q, Kawa LB, Ching CK, Sim DK. Hoong CW, et al. J Cardiovasc Med (Hagerstown). 2015 Sep;16(9):583-90. doi: 10.2459/JCM.0000000000000100. J Cardiovasc Med (Hagerstown). 2015. PMID: 25022929 Review. - The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis.
Meta-analysis Global Group in Chronic Heart Failure (MAGGIC). Meta-analysis Global Group in Chronic Heart Failure (MAGGIC). Eur Heart J. 2012 Jul;33(14):1750-7. doi: 10.1093/eurheartj/ehr254. Epub 2011 Aug 6. Eur Heart J. 2012. PMID: 21821849 Review.
Cited by
- Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trial.
Sakata Y, Shiba N, Takahashi J, Miyata S, Nochioka K, Miura M, Takada T, Saga C, Shinozaki T, Sugi M, Nakagawa M, Sekiguchi N, Komaru T, Kato A, Fukuchi M, Nozaki E, Hiramoto T, Inoue K, Goto T, Ohe M, Tamaki K, Ibayashi S, Ishide N, Maruyama Y, Tsuji I, Shimokawa H; SUPPORT Trial Investigators; SUPPORT Trial Investigators. Sakata Y, et al. Eur Heart J. 2015 Apr 14;36(15):915-23. doi: 10.1093/eurheartj/ehu504. Epub 2015 Jan 30. Eur Heart J. 2015. PMID: 25637937 Free PMC article. Clinical Trial. - Prevalence, predictors, and outcomes of cardiorenal syndrome in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry.
Kaddourah A, Goldstein SL, Lipshultz SE, Wilkinson JD, Sleeper LA, Lu M, Colan SD, Towbin JA, Aydin SI, Rossano J, Everitt MD, Gossett JG, Rusconi P, Kantor PF, Singh RK, Jefferies JL. Kaddourah A, et al. Pediatr Nephrol. 2015 Dec;30(12):2177-88. doi: 10.1007/s00467-015-3165-8. Epub 2015 Jul 26. Pediatr Nephrol. 2015. PMID: 26210985 Free PMC article. - Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone.
Shah AM, Claggett B, Sweitzer NK, Shah SJ, Anand IS, Liu L, Pitt B, Pfeffer MA, Solomon SD. Shah AM, et al. Circulation. 2015 Aug 4;132(5):402-14. doi: 10.1161/CIRCULATIONAHA.115.015884. Epub 2015 Jun 30. Circulation. 2015. PMID: 26130119 Free PMC article. Clinical Trial. - Evaluation of exercise capacity using wave intensity in chronic heart failure with normal ejection fraction.
Takaya Y, Taniguchi M, Sugawara M, Nobusada S, Kusano K, Akagi T, Ito H. Takaya Y, et al. Heart Vessels. 2013 Mar;28(2):179-87. doi: 10.1007/s00380-011-0224-3. Heart Vessels. 2013. PMID: 22302558 - Diastolic dysfunction and cardiac troponin I decrease in aging hearts.
Pan B, Xu ZW, Xu Y, Liu LJ, Zhu J, Wang X, Nan C, Zhang Z, Shen W, Huang XP, Tian J. Pan B, et al. Arch Biochem Biophys. 2016 Aug 1;603:20-8. doi: 10.1016/j.abb.2016.05.008. Epub 2016 May 13. Arch Biochem Biophys. 2016. PMID: 27184165 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous